98%
921
2 minutes
20
Early brain injury after a subarachnoid hemorrhage is an important prognostic factor. Aging is also an important prognostic factor of subarachnoid hemorrhage. However, the association between early brain injury and aging remains unclear. Older patients have comorbidities and frailty that can affect early brain injury severity. The purpose of this retrospective study was to clarify the differences in early brain injury severity between young and older patients by adjusting for comorbidities and frailty using propensity score matching. Between 2013 and 2021, 433 patients with subarachnoid hemorrhage who presented within 72 hrs of onset were included. The patients were divided into 2 groups: those aged 18-65 years (young group) and those aged ≥75 years (older group). The primary end point was early brain injury, which comprised the clinical, radiological, and laboratory findings on admission. We used propensity score matching to adjust for histories, comorbidities, and frailty. We analyzed early brain injury in the 2 groups for both non-propensity score matching and propensity score matching cohorts. Within the non-propensity score matching cohort, 260 patients were included in the young group and 173 in the older group. The propensity score matching cohort comprised 98 patients from both groups. The older group showed a higher World Federation of Neurosurgical Societies grade (p < 0.001), higher Hijdra scale (p < 0.01), and higher proportion of acute hydrocephalus (p < 0.001) in both cohorts. The study indicated exacerbated early brain injury among older patients, with worsening neurological damage, increasing subarachnoid hemorrhage volume, and causing hydrocephalus. Clarifying the impact of aging on early brain injury may help develop therapeutic interventions for subarachnoid hemorrhage.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12229749 | PMC |
http://dx.doi.org/10.2176/jns-nmc.2024-0326 | DOI Listing |
JCI Insight
September 2025
Edinburgh Medical School: Biomedical Sciences & Euan MacDonald Centre for M, University of Edinburgh, Edinburgh, United Kingdom.
Spinal muscular atrophy (SMA) is a neuromuscular disease caused by low levels of SMN protein. Several therapeutic approaches boosting SMN are approved for human patients, delivering remarkable improvements in lifespan and symptoms. However, emerging phenotypes, including neurodevelopmental comorbidities, are being reported in some treated SMA patients, indicative of alterations in brain development.
View Article and Find Full Text PDFJ Neurooncol
September 2025
Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Purpose: Glioblastoma (GBM) remains one of the most aggressive primary brain tumors with poor survival outcomes and a lack of approved therapies. A promising novel approach for GBM is the application of photodynamic therapy (PDT), a localized, light-activated treatment using tumor-selective photosensitizers. This narrative review describes the mechanisms, delivery systems, photosensitizers, and available evidence regarding the potential of PDT as a novel therapeutic approach for GBM.
View Article and Find Full Text PDFJ Neurooncol
September 2025
Department of Brain and Neurosciences, Division of Neurosurgery, Faculty of Medicine, Tottori University, Tottori, Japan.
Introduction: Hypertension, the most common adverse events associated with bevacizumab (BEV) treatment, has been proposed as a potential biomarker of treatment response in glioblastoma (GBM) patients. This study aimed to evaluate whether the timing of hypertension serves as a prognostic value in GBM patients.
Methods: This retrospective study consisting of 56 GBM patients treated with initial BEV between 2013 and 2024.
Epigenomics
September 2025
College of Physical Education, Yangzhou University, Yangzhou, China.
Background: Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder lacking objective biomarkers for early diagnosis. DNA methylation is a promising epigenetic marker, and machine learning offers a data-driven classification approach. However, few studies have examined whole-blood, genome-wide DNA methylation profiles for ASD diagnosis in school-aged children.
View Article and Find Full Text PDFNeurol Res
September 2025
Electrophysiology Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Objectives: This study aimed to investigate the effects of repeated exposure to sevoflurane as an anesthetic agent during various developmental stages, namely neonatal, preadolescent, and adult, on behavioral, synaptic, and neuronal plasticity in male and female Wistar rats.
Methods: Rats were exposed to sevoflurane during three developmental stages: neonatal (PN7), pre-adolescence (PN28), and adulthood (PN90). Behavioral performance was evaluated with the Morris Water Maze.